Cargando…
SAT-607 The Vagus Nerve and the Hypothalamus Mediate Different Aspects of the Anorectic Effects of PYY(3-36)
Background: Drugs that safely promote weight loss are required to treat the obesity crisis. The gut hormone peptide YY 3-36 (PYY(3-36)) is secreted post-prandially to suppress appetite via the Y2 receptor (Y2R). However, it is unclear whether PYY(3-36) acts directly on the Y2R in the hypothalamic ar...
Autores principales: | Alonso, Aldara Martin, Cork, Simon C, Ma, Yue, Arnold, Myrtha, Herzog, Herbert, Bloom, Stephen R, Distaso, Walter, Murphy, Kevin Graeme, Salem, Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207319/ http://dx.doi.org/10.1210/jendso/bvaa046.1337 |
Ejemplares similares
-
SUN-607 Iron Parameters in Patients with Partial Lipodystrophy and Impact of Metreleptin Therapy
por: Boutros, Sabine, et al.
Publicado: (2020) -
SAT-587 Molecular Markers of Beige Adipose Following ESR1 Knockdown in the Mediobasal Hypothalamus of Adult Female Rhesus Monkeys
por: Bandaru, Sindhura, et al.
Publicado: (2020) -
ODP607 Long-term Efficacy of Setmelanotide in Patients With POMC or LEPR Deficiency Obesity
por: Clément, Karine, et al.
Publicado: (2022) -
MON-099 Age-Related Differences in Appetite Regulation among Adults with Obesity: More Than Just Hunger and PYY and Ghrelin? Oh My!
por: Iwamoto, Sean, et al.
Publicado: (2019) -
MON-607 Very Low-Calorie Ketogenic Diet Modifies Visceral Adipose Tissue Distribution and Taxonomic Composition of Gut Microbiota in Obese Patients with Insulin Resistance Depending on Protein Source
por: Basciani, Sabrina, et al.
Publicado: (2020)